- Home
- RNAZ vs PWCM Comparison
RNAZ vs PWCM Comparison
Compare RNAZ & PWCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.65
Company Overview
Basic Information| Metric | RNAZ | PWCM |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | United States |
| Employees | N/A | 19 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0M | 2.0M |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | RNAZ | PWCM |
|---|---|---|
| Price | $1.65 | $1.02 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 50.8K | ★ 471.2K |
| Earning Date | 04-15-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 34.66 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $8,844,733.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.63 | $1.02 |
| 52 Week High | $20.99 | $2.27 |
Technical Indicators
Market Signals| Indicator | RNAZ | PWCM |
|---|---|---|
| Relative Strength Index (RSI) | 23.92 | 35.39 |
| Support Level | N/A | $1.02 |
| Resistance Level | $9.37 | $1.23 |
| Average True Range (ATR) | 0.22 | 0.11 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 1.89 | 9.33 |
Price Performance
Historical Comparison RNAZ
PWCM
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.